Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Theranostics Logo
Theranostics CB Rank
1029399
Heat Score
64
Theranostics is a journal that publishes research articles in the field of vitro diagnostics, prognostics, and molecular therapeutics.
Founded
obfuscation
Private Sydney, New South Wales, Australia11-50 www.thno.org
Analytics
Journalism
Medical
Publishing
Overview

Theranostics
Heat Score
64

Growth Score
pts
in past quarter
Heat Score 64
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Theranostics

CB Rank
1029399
Theranostics is a journal that publishes research articles in the field of vitro diagnostics, prognostics, and molecular therapeutics.
Founded
obfuscation
Private Sydney, New South Wales, Australia11-50 www.thno.org
Analytics
Journalism
Medical
Publishing

Details

Legal Name Theranostics
Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Theranostics Journal
A multidisciplinary open access journal publishing research articles in vitro diagnostics, prognostics, molecular therapeutics, molecular imaging, image-guided therapy, biosensors, and translational medicine.
Rainbow Plasmonic Nanobubbles
A method using clusters of different gold nanoparticles activated by multiple laser pulses to generate tunable vapor nanobubbles for selective cell-level diagnosis and therapy.

Research & Development

Theranostics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News

News and Press

News•Mar 20, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 4, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

52,047
-28.11%
 in past month

IT Spend

$447.7KThis year, Theranostics is projected to spend $447.7K on IT, according to Aberdeen.

Active Website Tech Count

2Theranostics is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 250k.
Sub-Organizations
Frequently Asked Questions

Where is Theranostics's headquarters? Theranostics is located in Sydney, New South Wales, Australia.Who are Theranostics's competitors? Alternatives and possible competitors to Theranostics may include Wiley, Nature Portfolio, and  Frontiers.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|